Off-label prescribing in pain medicine practice
FPM has published a new guidance document to inform the professional practice of FPM fellows and trainees.
The ethical and legal framework surrounding off-label prescribing in pain medicine has been a topic of discussion since the establishment of the Faculty of Pain Medicine (FPM). This complex issue arises from the need to balance patient care, professional judgment, and adherence to regulatory and ethical standards.
The faculty resolved to adopt the seven guiding principles for off label prescribing articulated by the Council of Australian Therapeutic Advisory Groups (CATAG) in their 2013 document entitled Rethinking medicines decision-making in Australian Hospitals; Guiding principles for the quality use of off label medicines.
A guidance document has been formulated to articulate the consensus views of the faculty leadership as well as reflect legal and ethical principles to inform the professional practice of FPM fellows and trainees.
For further information, please contact the faculty.
You might also be interested in...
Your monthly digest of professional document developments.
The NSW State Insurance Regulatory Authority (SIRA) has advised the SIRA set fees for the medical and surgical fees orders have been gazetted and indexed by 4.49%, commencing on 1 February 2025.
New this month: SCIDUA safety alert; Electronic medication management guidance; webAIRS update.